Latest Juvenile Diabetes Research Foundation Stories
SOUTHAMPTON, ENGLAND and NEW YORK, Jan. 9, 2012 /PRNewswire-USNewswire/ -- KalVista Pharmaceuticals ("KalVista") and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease. Diabetic eye disease is one of the most common and most serious complications in people with type 1 diabetes (T1D). JDRF will provide up to $2.2 million in milestone-based financial support and research...
--Goal of new JDRF research is to restore insulin production in people with type 1 diabetes-- NEW YORK, Dec. 13, 2011 /PRNewswire-USNewswire/ -- JDRF announced today its support of a pioneering diabetes research program that is developing a first-of-its-kind cell therapy for type 1 diabetes (T1D) and other forms of insulin-dependent diabetes. The therapy is a combination product that packages immature cells made from human embryonic stem cells (hESCs) that over time develop into...
INDIANAPOLIS, Dec. 2, 2011 /PRNewswire/ -- Roche Diabetes Care, makers of ACCU-CHEK products and services, is pleased to announce that Diabetes Living Today® Founder, President and CEO Kitty Castellini is the winner of Roche's inaugural Diabetes Heroes' Torchbearer Challenge. Roche launched the online Diabetes Heroes program earlier this year to highlight and recognize historic and present-day individuals who have made important contributions to help others live full lives...
Cellular movies could greatly enhance search for Type 1 disease interventions A war is being waged in the pancreases of millions of people throughout the world. The siege leads to the development of type 1 diabetes and has been a battlefield largely hidden from view-- until now. Researchers at the La Jolla Institute for Allergy & Immunology have created the first cellular movies showing the destruction underlying type 1 diabetes in real-time in mouse models. This detailed, dynamic view...
FDA's Draft Guidance Is A First Step to Providing Access to Life-Saving Technology for Millions with Type 1 Diabetes WASHINGTON, Dec. 1, 2011 /PRNewswire-USNewswire/ -- The JDRF today said it is encouraged that the Food and Drug Administration (FDA) has issued a draft guidance which appears to lay a foundation for accelerating the development and availability of artificial pancreas technology (AP) that will improve the lives of millions of Americans living with type 1 diabetes...
In Just 23 Days, Over 100,000 Individuals Sign Petition for the FDA to Advance, Not Delay, the Development of an Artificial Pancreas WASHINGTON, Nov. 2, 2011 /PRNewswire-USNewswire/ -- U.S. Senators, clinical experts, and people with type 1 diabetes (T1D) today urged the Food and Drug Administration (FDA) to issue clear and reasonable guidance on the artificial pancreas (AP) that avoids unnecessary delays in development and delivery of a medical technology and improves the lives of millions...
-- Two of the largest funders of type 1 diabetes research and development will collaborate in key priority areas to accelerate the pace of progress -- NEW YORK, Nov. 2, 2011 /PRNewswire-USNewswire/ -- JDRF and The Leona M. and Harry B. Helmsley Charitable Trust, two of the largest non-government funders of type 1 diabetes (T1D) programs, announced today that they have formalized a collaboration that will foster a new level of cooperation between the organizations. The goal of...
LANSING, Ill., Nov. 1, 2011 /PRNewswire/ -- Land O'Frost, the nation's largest family-owned packaged lunch meat brand, today announced a multi-year partnership with JDRF, focused on raising much-needed funds for type 1 diabetes (T1D) research and creating awareness of the organization and their efforts to cure, treat, and prevent T1D. This partnership builds on an informal relationship Land O'Frost has had with JDRF since 2008. Over the past three years, Land O'Frost employees have rallied...
RED BANK, N.J., Oct. 18, 2011 /PRNewswire/ -- For many years, Plymouth Rock employees and their families and friends have had a long-standing company tradition opening their hearts to raise money for a cause that is near and dear to Plymouth Rock - the Juvenile Diabetes Research Foundation (JDRF). On Sunday, October 9, over 170 Plymouth Rock employees participated in or volunteered for the 27th annual JDRF Walk to Cure Diabetes on the Avon-by-the-Sea Boardwalk, raising approximately $35,000...
HERSHEY, Pa., Sept. 27, 2011 /PRNewswire/ -- Organizers of the first-ever The Elegance at Hershey, a series of charitable vintage automobile events conducted at the Hotel Hershey® in June, Monday presented checks totaling $205,000 to its three beneficiaries. The Juvenile Diabetes Research Foundation (JDRF) received $105,000, while the AACA Antique Automobile Museum and the AACA Library and Research Center each received checks for $50,000. "Because of the generosity of our sponsors,...
